AstraZeneca Pharma India Ltd. (ASTR)

BSE
Currency in INR
9,138.10
+47.50(+0.52%)
Closed·
ASTR Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
ASTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,080.009,160.00
52 wk Range
6,222.3510,653.05
Key Statistics
Edit
Bid/Ask
9,101.00 / 9,175.00
Prev. Close
9,090.6
Open
9,080
Day's Range
9,080-9,160
52 wk Range
6,222.35-10,653.05
Volume
441
Average Vol. (3m)
3.71K
1-Year Change
31.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ASTR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

AstraZeneca Pharma India Ltd. Company Profile

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Employees
600
Market
India

Compare ASTR to Peers and Sector

Metrics to compare
ASTR
Peers
Sector
Relationship
P/E Ratio
197.4x34.3x−0.5x
PEG Ratio
−6.930.850.00
Price / Book
29.7x3.6x2.6x
Price / LTM Sales
13.3x3.8x3.1x
Upside (Analyst Target)
-4.5%47.6%
Fair Value Upside
Unlock0.2%6.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 46.30%
Dividend Yield
0.26%
Industry Median 0.69%
Annualized Payout
24.00
Paid annually
5-Years Growth
+100.00%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
23.30 / --
Revenue / Forecast
4.97B / --
EPS Revisions
Last 90 days

ASTR Income Statement

People Also Watch

345.25
APP
+1.06%
48.42
HIMS
+0.92%
2,539.85
INMR
-0.25%
126.26
VRT
-1.24%

FAQ

What Is the AstraZeneca Pharma India Ltd. (ASTR) Stock Price Today?

The AstraZeneca Pharma India Ltd. stock price today is 9,138.10

What Stock Exchange Does AstraZeneca Pharma India Ltd. Trade On?

AstraZeneca Pharma India Ltd. is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for AstraZeneca Pharma India Ltd.?

The stock symbol for AstraZeneca Pharma India Ltd. is "ASTR."

Does AstraZeneca Pharma India Ltd. Pay Dividends? What’s The Current Dividend Yield?

The AstraZeneca Pharma India Ltd. dividend yield is 0.26%.

What Is the AstraZeneca Pharma India Ltd. Market Cap?

As of today, AstraZeneca Pharma India Ltd. market cap is 228.45B.

What Is AstraZeneca Pharma India Ltd.'s Earnings Per Share (TTM)?

The AstraZeneca Pharma India Ltd. EPS (TTM) is 46.30.

When Is the Next AstraZeneca Pharma India Ltd. Earnings Date?

AstraZeneca Pharma India Ltd. will release its next earnings report on Aug 11, 2025.

From a Technical Analysis Perspective, Is ASTR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has AstraZeneca Pharma India Ltd. Stock Split?

AstraZeneca Pharma India Ltd. has split 1 times.

How Many Employees Does AstraZeneca Pharma India Ltd. Have?

AstraZeneca Pharma India Ltd. has 600 employees.

What is the current trading status of AstraZeneca Pharma India Ltd. (ASTR)?

As of Jul 08, 2025, AstraZeneca Pharma India Ltd. (ASTR) is trading at a price of 9,138.10, with a previous close of 9,090.60. The stock has fluctuated within a day range of 9,080.00 to 9,160.00, while its 52-week range spans from 6,222.35 to 10,653.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.